Literature DB >> 11049757

High-level expression of human liver monoamine oxidase B in Pichia pastoris.

P Newton-Vinson1, F Hubalek, D E Edmondson.   

Abstract

The high-level heterologous expression, purification, and characterization of the mitochondrial outer membrane enzyme human liver monoamine oxidase B (MAO B) using the methylotrophic yeast Pichia pastoris expression system are described. A 2-L culture of P. pastoris expresses approximately 1700 U of MAO B activity, with the recombinant enzyme associated tightly with the membrane fraction of the cell lysate. By a modification of the published procedure for purification of bovine liver MAO B [Salach, J. I. (1979) Arch. Biochem. Biophys. 192, 128-137], recombinant human liver MAO B is purified in a 34% yield ( approximately 200 mg from 2 L of cell culture). The isolated enzyme exhibits an M(r) of approximately 60, 000 on SDS-PAGE and 59,474 from electrospray mass spectrometry measurements, which is in good agreement with the mass predicted from the gene sequence and inclusion of the covalent FAD. One mole of covalent FAD per mole of MAO B is present in the purified enzyme and is bound by an 8alpha-S-cysteinyl(397) linkage, as identified by electrospray mass spectrometry of the isolated tryptic/chymotryptic flavin peptide. Recombinant human liver MAO B and bovine liver MAO B are shown to be acetylated at the seryl residues at their respective amino termini. The benzylamine oxidase activity of recombinant MAO B ranges from 3.0 to 3.4 U/mg and steady-state kinetic parameters for this enzyme preparation compare well with those published for the bovine liver enzyme: k(cat) = 600 min(-1), K(m)(benzylamine) = 0.50 mM, and K(m)(O(2)) = 0.33 mM. Kinetic isotope effect parameters using [alpha,alpha-(2)H(2)]benzylamine are also similar to those found for the bovine enzyme. Recombinant MAO B exhibits a (D)k(cat) = 4.7, a (D)[k(cat)/K(m)(benzylamine)] = 4.5, and a (D)[k(cat)/K(m)(O(2))] = 1.0. In contrast to bovine liver MAO B, no evidence was found for the presence of any anionic flavin radical either by UV-vis or by EPR spectroscopy in the resting form of the enzyme. These data demonstrate the successful heterologous expression of a functional, membrane-bound MAO B, which will permit a number of mutagenesis studies as structural and mechanistic probes not previously possible. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11049757     DOI: 10.1006/prep.2000.1309

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  32 in total

1.  Interactions of monoamine oxidases with the antiepileptic drug zonisamide: specificity of inhibition and structure of the human monoamine oxidase B complex.

Authors:  Claudia Binda; Milagros Aldeco; Andrea Mattevi; Dale E Edmondson
Journal:  J Med Chem       Date:  2010-12-22       Impact factor: 7.446

2.  Molecular Insights into Human Monoamine Oxidase B Inhibition by the Glitazone Anti-Diabetes Drugs.

Authors:  Claudia Binda; Milagros Aldeco; Werner J Geldenhuys; Marcello Tortorici; Andrea Mattevi; Dale E Edmondson
Journal:  ACS Med Chem Lett       Date:  2011-10-15       Impact factor: 4.345

Review 3.  Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B.

Authors:  Dale E Edmondson; Claudia Binda; Andrea Mattevi
Journal:  Arch Biochem Biophys       Date:  2007-05-30       Impact factor: 4.013

4.  Structural and mechanistic studies of mofegiline inhibition of recombinant human monoamine oxidase B.

Authors:  Erika M Milczek; Daniele Bonivento; Claudia Binda; Andrea Mattevi; Ian A McDonald; Dale E Edmondson
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

Review 5.  Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases.

Authors:  Dale E Edmondson; Claudia Binda; Jin Wang; Anup K Upadhyay; Andrea Mattevi
Journal:  Biochemistry       Date:  2009-05-26       Impact factor: 3.162

6.  Binding of rasagiline-related inhibitors to human monoamine oxidases: a kinetic and crystallographic analysis.

Authors:  Claudia Binda; Frantisek Hubálek; Min Li; Yaacov Herzig; Jeffrey Sterling; Dale E Edmondson; Andrea Mattevi
Journal:  J Med Chem       Date:  2005-12-29       Impact factor: 7.446

Review 7.  On the practical aspects of characterising monoamine oxidase inhibition in vitro.

Authors:  Andrew Holt
Journal:  J Neural Transm (Vienna)       Date:  2018-10-29       Impact factor: 3.575

8.  High-level expression and purification of rat monoamine oxidase A (MAO A) in Pichia pastoris: comparison with human MAO A.

Authors:  Jin Wang; Dale E Edmondson
Journal:  Protein Expr Purif       Date:  2009-10-31       Impact factor: 1.650

9.  Development of spin-labeled pargyline analogues as specific inhibitors of human monoamine oxidases A and B.

Authors:  Anup K Upadhyay; Dale E Edmondson
Journal:  Biochemistry       Date:  2009-05-12       Impact factor: 3.162

10.  Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures.

Authors:  Claudia Binda; Min Li; Frantisek Hubalek; Nadia Restelli; Dale E Edmondson; Andrea Mattevi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.